The term cervical erosion is a misleading legacy name and the correct medical term is cervical ectropion. The cervix has two zones of cells: the outer cervix (visible in the vagina) is normally covered by tough squamous cells that look pink, and the inner cervical canal is lined by softer red glandular cells that produce mucus. When the glandular cells from inside the canal extend onto the outer cervix, the OB sees a red ring or patch around the cervical opening on speculum examination. This is ectropion, and despite the word erosion it is not a wound, ulcer, or injury. The cells are simply in a different location than the textbook diagram shows.

Ectropion is extremely common — studies estimate it is present in around one in three women of reproductive age at any given time, with even higher rates in young women, women on hormonal contraception, and during pregnancy. It looks alarming on speculum because the glandular cells are thinner and bleed more easily on touch, but the appearance is not a marker of disease. The honest framing is that ectropion is a normal variant of cervical anatomy in many healthy women, not a pathological condition that demands treatment.

The confusion in Indian practice comes from older training that called any visible red area on the cervix an erosion and assumed it needed cautery. Modern FOGSI guidance and international gynaecology consensus is that asymptomatic ectropion needs no treatment and that the priority is to rule out cervical cancer and other serious causes of any bleeding or discharge before considering local treatment.

Ectropion is driven by oestrogen, which causes the glandular cells of the cervical canal to grow outwards onto the visible outer cervix. This is why it is most commonly seen during the high-oestrogen states of life: puberty and the teenage years, the reproductive years (especially in women on combined oral contraceptive pills which provide a steady oestrogen stimulus), and pregnancy when oestrogen levels rise dramatically. After menopause when oestrogen falls, ectropion typically regresses on its own without any treatment.

Ectropion is not caused by sexual activity, rough intercourse, IUD insertion, douching, tampon use, or any kind of mechanical injury. It is also not caused by infection, poor hygiene, or any dietary factor, despite what some traditional belief systems suggest. The cells are not damaged or wounded — they are simply normal glandular cells that have grown into a slightly different position because of the hormonal environment. Many young Indian women are told that their ectropion is the result of early sexual activity or rough sex, and this is medically incorrect and causes unnecessary guilt.

Because ectropion responds to oestrogen, it often resolves spontaneously when the hormonal trigger is removed: after stopping the combined pill, after pregnancy and during breastfeeding, and after menopause. This natural resolution is one of the main reasons that no treatment is the right approach for the majority of asymptomatic women, because the condition often disappears on its own with time.

The most important fact about cervical ectropion is that the great majority of women with it have no symptoms whatsoever and are only diagnosed incidentally during a routine speculum examination for another reason such as a Pap smear or contraceptive review. Asymptomatic ectropion is a normal variant, requires no investigation beyond confirming there is nothing else going on, and needs no treatment.

When symptoms do appear, the most common are post-coital spotting (a small amount of bright red blood after intercourse, because the thin glandular cells bleed easily on contact), increased vaginal discharge (typically clear, watery, or pale yellow and not foul-smelling because the glandular cells produce mucus and more cells means more mucus), and occasional mild pelvic discomfort or a sensation of wetness. Bleeding between periods is sometimes attributed to ectropion but should always be investigated for other causes first.

It is important to be clear about what ectropion does not cause. It does not cause heavy menstrual bleeding, severe pelvic pain, fever, foul-smelling discharge, infertility, miscarriage, or any systemic illness. If any of these symptoms are present, the cause is not the ectropion and the workup needs to look elsewhere. The temptation to attribute every cervical symptom to a visible ectropion is one of the main reasons that real causes get missed.

A common scenario in Indian gynaecology is that a woman presents with post-coital bleeding or increased discharge, the GP or OB performs a speculum examination, sees a red area around the cervical opening, labels it cervical erosion, and recommends cautery on the same visit or the next one. This pattern is widespread but it is medically wrong, because a red-looking cervix on speculum can have several causes and ectropion is only one of them. Treating the appearance without identifying the cause means the real problem is potentially missed.

The serious causes that can look like or coexist with ectropion include cervical cancer (which can present as a red friable area that bleeds on contact), cervical polyps (small soft growths from the cervical canal that bleed easily), cervicitis from chlamydia or gonorrhoea (which causes inflammation of the cervix with discharge and contact bleeding), trichomonas infection, and trauma. Cautery for an assumed erosion in a woman who actually has early cervical cancer is genuinely harmful because it can delay the diagnosis by months or years.

FOGSI and modern Indian gynaecology training now teach that no woman should have her cervix cauterised for assumed erosion without first having a Pap smear (and ideally an HPV test) to rule out cervical cancer and precancerous changes, and an STI screen if the history suggests it. The honest framing is that the speculum appearance alone is not enough to make a treatment decision.

Post-coital bleeding (bleeding after intercourse) is the single most important symptom that overlaps between ectropion and cervical cancer, and any post-coital bleeding deserves a proper workup before being attributed to erosion. The required first step is a Pap smear with or without HPV testing, because cervical cancer in its early stages often presents exactly as post-coital spotting with a red-looking cervix, and missing it at this stage means missing the window for curative treatment. If the Pap and HPV are normal and the bleeding continues, colposcopy is the next step to look at the cervix in detail.

Other red flags that mean the appearance is probably not just ectropion include foul-smelling or greenish discharge (suggests bacterial vaginosis, trichomonas, or cervicitis from chlamydia or gonorrhoea), heavy bleeding between periods, post-menopausal bleeding (always abnormal and always needs investigation), pelvic pain or fever (suggests pelvic inflammatory disease), and a hard, irregular, or fixed-feeling cervix on examination. Any of these means the workup goes beyond simply labelling the appearance as erosion.

An STI screen is particularly important in women under thirty, those with new or multiple partners, and those whose symptoms include discharge or pelvic discomfort, because chlamydia and gonorrhoea are common in Indian populations, are often asymptomatic, and can mimic ectropion. Treating an STI-driven cervicitis with cautery instead of antibiotics is genuinely harmful. For more on post-coital bleeding causes see bleeding-after-sex-india.

The correct workup for a red-looking cervix in India starts with a thorough speculum examination by an OB-GYN to describe the appearance and rule out obvious polyps, ulcers, or masses. A Pap smear should be performed if the woman is due for cervical cancer screening or if she has any abnormal bleeding or discharge — Pap smears cost around five hundred to two thousand five hundred rupees at private labs (Dr Lal PathLabs, Metropolis, Thyrocare, SRL) and are free at PHC and district hospital level under the National Cervical Cancer Screening programme. For more on Pap smears see pap-smear-first-time-india.

HPV DNA testing is increasingly used either alongside the Pap smear or as a primary screening test in women aged thirty and above, and costs around two thousand to five thousand rupees at private labs in India. A negative HPV test combined with a normal Pap is very reassuring against cervical cancer or precancer. If either test is abnormal or if bleeding persists despite normal screening, colposcopy is the next step — a magnified visual examination of the cervix with biopsy of any suspicious area, available at most private hospitals and tertiary government hospitals for around one thousand five hundred to four thousand five hundred rupees.

An STI screen is added when the history suggests it, and typically includes chlamydia and gonorrhoea PCR, trichomonas wet mount, and where appropriate testing for syphilis and HIV. Only after all of this is done and the serious causes have been ruled out is it appropriate to label the appearance as ectropion. For more on HPV testing see hpv-types-symptoms-treatment-india.

For the great majority of women with cervical ectropion, the correct treatment is no treatment, and the right conversation is reassurance. If the ectropion is found incidentally on a routine examination, the woman is asymptomatic, the Pap smear and HPV are normal, and there is no concerning discharge or bleeding, the appropriate plan is simply to continue routine cervical cancer screening and to do nothing about the ectropion itself.

This is also the right approach when the ectropion is found in specific situations where it is expected to resolve on its own. Ectropion in women on combined oral contraceptive pills often regresses within a few months of stopping the pill or switching to a non-hormonal method. Ectropion during pregnancy almost always resolves within a few months postpartum once oestrogen levels fall. Ectropion in young women who are not on hormonal contraception often regresses gradually over years and disappears after menopause. None of these scenarios needs cautery or any local procedure.

Reassurance is not a passive non-treatment — it is the active correct treatment for a normal variant, and it spares the woman an unnecessary procedure with its own risks and costs. FOGSI guidance and international gynaecology consensus are clear that asymptomatic ectropion does not require treatment, and any Indian OB or GP who recommends cautery for asymptomatic erosion is going against current evidence.

Treatment for cervical ectropion is considered only when two conditions are met together: the woman has genuinely troublesome symptoms (recurrent post-coital bleeding, persistent heavy clear or yellow discharge, or significant discomfort that affects daily life or intercourse), and all other causes have been properly ruled out (normal Pap, normal HPV, no STI, no polyp, no other pathology on colposcopy). If either condition is missing, treatment is not the right answer.

When treatment is appropriate, several local procedures are available in India. Cryotherapy uses a freezing probe to destroy the glandular cells on the outer cervix, allowing the tougher squamous cells to grow back over the area; it is the most commonly used option, takes a few minutes in OPD, and recovery involves a watery discharge for a few weeks. Electrocautery uses heat to achieve the same effect, is also a short OPD procedure, and is widely available in Indian private and government hospitals. Silver nitrate application is a chemical option for smaller areas. Laser ablation is available at some tertiary centres but is more expensive.

Recovery after any of these involves abstaining from intercourse, tampons, and douching for around four to six weeks to allow healing, and a discharge that gradually decreases over a few weeks. Most women see symptom improvement, though recurrence is possible especially if the hormonal trigger continues. The procedure is generally well tolerated and complications are uncommon when performed by an experienced OB.

The diagnostic workup for a cervical complaint in India ranges from free in government settings to a few thousand rupees in private. A Pap smear costs around five hundred to two thousand five hundred rupees at private labs and is free at PHC and district hospitals under the National Cervical Cancer Screening programme. HPV DNA testing costs around two thousand to five thousand rupees at Dr Lal PathLabs, Metropolis, Thyrocare, and SRL. Colposcopy with biopsy if needed costs around one thousand five hundred to four thousand five hundred rupees at private hospitals and is available free at most tertiary government hospitals.

Treatment costs when it is appropriate are also affordable. Cryotherapy in private OPD costs around one thousand five hundred to four thousand rupees including the consultation. Electrocautery costs around two thousand to five thousand rupees at private hospital chains including Apollo, Fortis, Manipal, Max, and Cloudnine. Silver nitrate application is the cheapest at around five hundred to one thousand five hundred rupees and is done as an OPD procedure. All of these are typically free at government tertiary hospitals and district hospitals.

Access through public schemes includes the National Cervical Cancer Screening programme that offers free Pap or visual inspection at primary health centres and district hospitals, the PMSMA clinics on the ninth of each month for free OB consultation, and eSanjeevani telehealth for an initial consultation if a local OB is not easily available. Ayushman Bharat PMJAY covers cervical procedures for eligible families at empanelled hospitals.

The single most important thing to avoid is accepting cautery for an asymptomatic cervical ectropion. If a GP or OB sees a red cervix on routine speculum examination and recommends same-day cautery without first asking about symptoms and without ordering a Pap smear and HPV test, that recommendation is not consistent with current FOGSI guidance and you should ask for a Pap and HPV first, and a second opinion if needed. The cautery itself is not very risky, but it is unnecessary and it does not address any real problem.

Equally important is to avoid the opposite mistake: assuming that because you have been told you have erosion, all your bleeding or discharge is explained and no further investigation is needed. Cervical cancer can coexist with ectropion or can be misdiagnosed as ectropion, so the screening with Pap and HPV must still happen on schedule. A normal Pap and HPV result is what gives genuine reassurance, not a label of erosion.

Avoid also the family or pharmacist advice to use vaginal douches, antiseptic washes, herbal preparations, or unproven local applications for an assumed erosion. These do not help and can cause irritation or alter the vaginal flora. The correct approach is the structured workup with a qualified OB-GYN and then either reassurance or properly indicated treatment, not informal local treatments.